Buffered Lidocaine Syringes at Brooke Army Medical Center, JBSA Ft. Sam Houston, TX

The Department of the Army, W40M MRC0 WEST, has issued solicitation W81K00-26-Q-A001 for the procurement of buffered lidocaine syringes for Brooke Army Medical Center at JBSA Fort Sam Houston, Texas. This requirement is a combined synopsis and solicitation designated as an SBA Small Business Administration set-aside. The procurement is classified under NAICS 325412, Pharmaceutical Preparation Manufacturing, and PSC 6515, Medical and Surgical Instruments, Equipment, and Supplies. Contractors must demonstrate proof of compliance with federal Food and Drug Administration regulations and applicable state regulations regarding the production and distribution of the requested medical products.

Quotes are due no later than 11:00 AM CT on June 24, 2026, and must be submitted via email to Patrick Thielemann and Christopher Gregory. Submissions must include a completed SF1449 with the firm’s CAGE code and Unique Entity ID, along with a statement that the offer will remain firm for at least 90 days. Evaluation factors for this award include price and compliance with specifications. All offerors are required to have an active registration in the System for Award Management (SAM) to be eligible for award.

The government issued two attachments for this opportunity, including the primary solicitation and an amendment posted on June 10, 2026. Questions concerning this solicitation must be submitted in writing by 11:00 AM CT on June 15, 2026. Electronic files exceeding 20MB must be sent in separate emails to ensure the government server successfully receives the entire submission by the established deadline.